+138.2%
CIFR vs THC
+423.7%
-285.5%
-81.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.1% | -0.3% | -3.8% | -4.0% |
| 7D | +4.8% | +1.0% | +3.9% | +4.8% |
| 30D | -31.0% | +5.3% | -36.3% | -31.1% |
| 3M | -58.7% | +7.1% | -65.8% | -58.9% |
| 6M | -67.7% | +46.0% | -113.7% | -69.4% |
| YTD | -53.5% | +43.9% | -97.5% | -55.8% |
| 1Y | -54.1% | +45.4% | -99.5% | -56.4% |
| 3Y | +138.2% | +421.3% | -283.1% | +21.7% |
| All | +138.2% | +423.7% | -285.5% | +21.7% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling